Canary Capital’s XRPC Larger Than All Other U.S. Spot XRP ETFs Combined as of 11/26/25 and HBR Establishes First-of-Its-Kind U.S. Spot HBAR Exposure




Canary Capital’s XRPC Larger Than All Other U.S. Spot XRP ETFs Combined as of 11/26/25 and HBR Establishes First-of-Its-Kind U.S. Spot HBAR Exposure

Canary’s expanding ETF suite surpasses $400M in combined assets amid accelerating institutional demand

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Canary Capital Group LLC (“Canary Capital”), a digital asset–focused investment firm, announced that its assets under management (AUM) in Canary XRP ETF (Nasdaq: XRPC) is greater than all other U.S.-listed spot XRP ETFs combined.¹ Totaling more than $336 million in AUM since its launch, XRPC leads the market as the largest spot XRP ETF in the United States as of 11/26/25.

The fund’s debut earlier this month was marked by a record-setting $59 million in day-one trading volume, the highest first-day volume of any ETF launched in 2025.²

“What we’re seeing with XRPC is more than early adoption, it’s validation of where investor demand is heading,” said Steven McClurg, CEO and Founder of Canary Capital. “That’s a clear signal that investors are choosing XRPC as a preferred vehicle for exposure to one of the most foundational digital assets.”

XRPC holds XRP, the native token of the XRP Ledger, a decentralized network used globally for real-time value transfer, asset tokenization, and settlement infrastructure.

As part of Canary Capital’s broader mission to expand access to blockchain-powered investment opportunities, the firm also launched Canary HBAR ETF (Nasdaq: HBR) earlier this quarter. HBR is the first and only U.S.-listed ETF providing spot exposure to HBAR, the native token of the Hedera network. With over $65 million in assets, HBR offers investors access to a high-throughput, energy-efficient platform designed for real-world enterprise applications.

Canary’s expanding suite of digital asset ETFs reflects its commitment to building forward-looking investment vehicles that combine market access with real utility and institutional rigor in emerging markets.

To learn more about XRPC and HBR, visit:

https://etfs.canary.capital/xrpc/
https://etfs.canary.capital/hbr/

About Canary Capital

Canary Capital is an investment management firm that blends rigorous risk management, strategic foresight, and innovative thinking to deliver private placement strategies, crypto hedge fund solutions, treasury management solutions, and publicly traded funds, with a focus on enterprise technology.

Disclosures

XRPC and HBR (the “Funds”) are not registered commodity pools or investment companies registered under the Investment Company Act of 1940. Shares of the Funds are not subject to the same regulatory requirements as mutual funds.

These investments are not suitable for all investors. Funds focusing on single assets generally experience greater volatility. Please ask your financial advisor for more information about these risks. Digital assets, such as XRP and HBAR, are a relatively new asset class, and the market for digital assets is subject to rapid changes and uncertainty. Digital assets are largely unregulated and digital asset investments may be more susceptible to fraud and manipulation than more regulated investments.

Investing Involves Significant Risk. The loss of principal is possible. The Funds may not be suitable for all investors. This document does not constitute a recommendation of any investment strategy or product for a particular investor. Investors should consult a financial advisor/financial consultant before making any investment decisions.

The Funds’ investment objectives, risks, charges and expenses should be considered before investing. The prospectuses contain this and other important information, and it may be obtained at https://etfs.canary.capital/XRPC/prospectus/ and https://etfs.canary.capital/HBR/prospectus/. Read them carefully before investing.

The Funds are not actively managed and will not take any actions to take advantage, or mitigate the impacts, of volatility in the price of XRP or HBAR. Investments in the Funds are not a direct investment in XRP or HBAR. Investors will not have any rights that XRP or HBAR holders have and will not have the right to receive any redemption proceeds in XRP or HBAR. Shares of the Funds are generally bought and sold at market price (not NAV) and are not individually redeemed from the Funds. Only Authorized Participants may trade directly with the Funds and only in large blocks of Shares called “creation units.” Your brokerage commissions will reduce returns.

The Funds’ Marketing Agent is Paralel Distributors LLC which is not affiliated with Canary Capital Group LLC or its affiliates.

CNRY81

Contacts

Media

Trevor Davis

Gregory FCA for Canary Capital

215-475-5931

trevor@gregoryfca.com

Investor Relations

Amber Reedy

Canary Capital

amber.reedy@canary.capital

Canary Capital’s XRPC Larger Than All Other U.S. Spot XRP ETFs Combined as of 11/26/25 and HBR Establishes First-of-Its-Kind U.S. Spot HBAR Exposure




Canary Capital’s XRPC Larger Than All Other U.S. Spot XRP ETFs Combined as of 11/26/25 and HBR Establishes First-of-Its-Kind U.S. Spot HBAR Exposure

Canary’s expanding ETF suite surpasses $400M in combined assets amid accelerating institutional demand

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Canary Capital Group LLC (“Canary Capital”), a digital asset–focused investment firm, announced that its assets under management (AUM) in Canary XRP ETF (Nasdaq: XRPC) is greater than all other U.S.-listed spot XRP ETFs combined.¹ Totaling more than $336 million in AUM since its launch, XRPC leads the market as the largest spot XRP ETF in the United States as of 11/26/25.

The fund’s debut earlier this month was marked by a record-setting $59 million in day-one trading volume, the highest first-day volume of any ETF launched in 2025.²

“What we’re seeing with XRPC is more than early adoption, it’s validation of where investor demand is heading,” said Steven McClurg, CEO and Founder of Canary Capital. “That’s a clear signal that investors are choosing XRPC as a preferred vehicle for exposure to one of the most foundational digital assets.”

XRPC holds XRP, the native token of the XRP Ledger, a decentralized network used globally for real-time value transfer, asset tokenization, and settlement infrastructure.

As part of Canary Capital’s broader mission to expand access to blockchain-powered investment opportunities, the firm also launched Canary HBAR ETF (Nasdaq: HBR) earlier this quarter. HBR is the first and only U.S.-listed ETF providing spot exposure to HBAR, the native token of the Hedera network. With over $65 million in assets, HBR offers investors access to a high-throughput, energy-efficient platform designed for real-world enterprise applications.

Canary’s expanding suite of digital asset ETFs reflects its commitment to building forward-looking investment vehicles that combine market access with real utility and institutional rigor in emerging markets.

To learn more about XRPC and HBR, visit:

https://etfs.canary.capital/xrpc/
https://etfs.canary.capital/hbr/

About Canary Capital

Canary Capital is an investment management firm that blends rigorous risk management, strategic foresight, and innovative thinking to deliver private placement strategies, crypto hedge fund solutions, treasury management solutions, and publicly traded funds, with a focus on enterprise technology.

Disclosures

XRPC and HBR (the “Funds”) are not registered commodity pools or investment companies registered under the Investment Company Act of 1940. Shares of the Funds are not subject to the same regulatory requirements as mutual funds.

These investments are not suitable for all investors. Funds focusing on single assets generally experience greater volatility. Please ask your financial advisor for more information about these risks. Digital assets, such as XRP and HBAR, are a relatively new asset class, and the market for digital assets is subject to rapid changes and uncertainty. Digital assets are largely unregulated and digital asset investments may be more susceptible to fraud and manipulation than more regulated investments.

Investing Involves Significant Risk. The loss of principal is possible. The Funds may not be suitable for all investors. This document does not constitute a recommendation of any investment strategy or product for a particular investor. Investors should consult a financial advisor/financial consultant before making any investment decisions.

The Funds’ investment objectives, risks, charges and expenses should be considered before investing. The prospectuses contain this and other important information, and it may be obtained at https://etfs.canary.capital/XRPC/prospectus/ and https://etfs.canary.capital/HBR/prospectus/. Read them carefully before investing.

The Funds are not actively managed and will not take any actions to take advantage, or mitigate the impacts, of volatility in the price of XRP or HBAR. Investments in the Funds are not a direct investment in XRP or HBAR. Investors will not have any rights that XRP or HBAR holders have and will not have the right to receive any redemption proceeds in XRP or HBAR. Shares of the Funds are generally bought and sold at market price (not NAV) and are not individually redeemed from the Funds. Only Authorized Participants may trade directly with the Funds and only in large blocks of Shares called “creation units.” Your brokerage commissions will reduce returns.

The Funds’ Marketing Agent is Paralel Distributors LLC which is not affiliated with Canary Capital Group LLC or its affiliates.

CNRY81

Contacts

Media

Trevor Davis

Gregory FCA for Canary Capital

215-475-5931

trevor@gregoryfca.com

Investor Relations

Amber Reedy

Canary Capital

amber.reedy@canary.capital

GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025




GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025

• The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the care journey across smart devices and drugs throughout disease states enabled by cloud and AI solutions.
• GE HealthCare has invested more than $3B in R&D since 2022, delivering an innovation renaissance across disease states to advance precision care.

CHICAGO–(BUSINESS WIRE)–At this year’s Radiological Society of North America’s (RSNA) 2025 Annual Meeting, GE HealthCare (Nasdaq: GEHC) will showcase a wave of significant innovations grounded by its legacy and deep, global commitment to advancing precision care. For more than a century, GE HealthCare has stood at the intersection of medicine and technology—helping clinicians see more, understand more, and do more for their patients. What began with some of the world’s earliest technology innovations in medical imaging has evolved into a strong, global focus to advancing precision care.

Solving industry challenges

Radiology departments worldwide are facing unprecedented pressure. In the coming years, healthcare providers are expected to encounter several critical challenges, including a shortage of qualified staff, rising demand for imaging services, rapid technological advancements, and the urgent need to improve operational efficiency across care settings.¹ Amid these challenges, GE HealthCare is developing cloud-based and AI-enabled innovations aimed at helping providers and clinicians turn data into actionable insights, deliver precise diagnoses and treatment plans faster than before, and help hospitals boost their efficiency.

At RSNA 2025, GE HealthCare will showcase more than 40 technology innovations that merge state-of-the-art imaging device technology with advanced digital, computational and AI capabilities and are designed to address these challenges head-on: from AI-enabled imaging systems that are designed to reduce cognitive load and automate routine tasks, to structured reporting tools that can streamline workflows and improve data consistency.

“As we shape the future of care, our commitment remains clear: to deliver transformative technologies that empower clinicians, drive efficiencies, and help improve patient outcomes across multiple care pathways,” said Peter Arduini, CEO of GE HealthCare. “We start by listening to our customers, and work backwards from their challenges, then develop truly differentiated products and solutions to meet their needs today and into the future.”

Key products driving GE HealthCare’s innovation renaissance

GE HealthCare is delivering bold new solutions designed to elevate patient care and enhance the clinician experience. Since 2022, GE HealthCare has invested more than $3 billion in research and development, fueling a wave of innovation across equipment, radiopharmaceuticals and cloud and AI-enabled solutions. This year at RSNA, GE HealthCare will demonstrate new and recently announced innovations, including:

• Photonova™ Spectra² (510(k) pending with the U.S. FDA; not available for sale): The new photon counting CT (PCCT) system with advanced AI algorithms,³ marks a major milestone in the company’s decades-long history in CT innovation. Built on GE HealthCare’s proprietary Deep Silicon detector technology, Photonova Spectra is designed to deliver remarkable spectral and spatial resolution for ultra-high-definition (UHD) imaging with wide coverage, seeking to enable fast acquisition speeds, precise visualization of anatomical structures and enhanced material separation. This system is designed to maximize the vast amounts of data provided, harnessing up to 50 times more data than conventional CT⁴ to enable advanced reconstruction techniques and precise outputs with the aim of supporting enhanced clinical decision-making and smooth workflows.
• Next-gen SIGNA MRI technology (510(k) pending at the U.S FDA; not available for sale): These technologies are designed to enhance precision diagnosis for clinicians. The innovations include:
  • SIGNA™ Bolt⁵ aims to bring to market our most advanced high-field, clinical wide bore 3.0T MRI system and is seeking to combine ultra-high gradient performance, intelligent digital RF architecture, and sustainable design to deliver precision imaging, fast workflows, and seamless clinical-to-research flexibility, all with exceptionally low energy consumption and operational costs.
  • SIGNA™ Sprint with Freelium™⁶ aims to broaden access to sustainable and equitable MRI technology. With less than 1% helium usage compared to conventional magnets, Freelium is designed to provide effortless sustainability without compromising clinical and operational efficiency.
  • Both are powered by SIGNA™ One⁷, an AI-powered workflow platform designed to improve the imaging experience by combining precision with simplicity.
• Pristina™ Recon DL: This solution is GE HealthCare’s advanced 3D mammography reconstruction technology—the first to combine deep learning with iterative reconstruction to provide outstanding digital breast tomosynthesis (DBT) image quality at a low patient radiation dose. Pristina Recon DL is an enhancement to GE HealthCare’s Pristina Via™ system. Pristina Via with Recon DL mammography system offers high clinical confidence and efficient workflows with exceptional patient experience.
• Vivid™ Pioneer: GE HealthCare’s most advanced and adaptive cardiovascular ultrasound platform. With one-click optimization, AI automation tools, simplified user interface and a lighter, compact, battery supported system, Vivid Pioneer is designed for extraordinary imaging, workflow, and comfort.
• Flyrcado™ (flurpiridaz F 18) injection: FDA-approved PET MPI agent for adult patients with known or suspected coronary artery disease to evaluate myocardial ischemia and infarction; higher diagnostic efficacy versus SPECT, exercise-stress PET enabled by a longer half-life, and ready-to-use unit dose to support adoption. Flyrcado is expected to reach a substantial number of cardiac PET centers in the U.S. as adoption continues. CMS traditional pass-through status (effective Apr 1, 2025) supports access in HOPD settings. U.S. audiences only.
• Definium Pace Select ET: An advanced floor-mounted digital X-ray system designed to deliver high-image quality and optimize efficiency in highly demanding environments while enhancing access and affordability. The system solves for many technologist challenges today by automating manual, repetitive steps and helping to reducing physical strain. The system leverages AI to help ensure accurate patient positioning and consistent image quality across various clinical conditions while streamlining the technologist workflow to maximize the patient experience and throughput.

GE HealthCare is at the forefront of developing advanced AI- and cloud-enabled capabilities to help improve workflow efficiency for radiologists. Key highlights this year include:

• Genesis™ Radiology Workspace⁸ anchored by Genesis Viewer (510(k) pending at the U.S FDA; not available for sale):⁹ Software that is designed to be an ultra-fast diagnostic, zero-footprint viewer – streamlining radiology workflows and aiming to enhance patient care while being fully accessible from any location. Genesis Viewer is part of the GE HealthCare’s Genesis™ Radiology Workspace to help radiologists streamline their workflows. The next-generation solution is designed to transform radiology workflows, unify the user experience, and empower radiologists with great efficiency and precision.
• 100 FDA-authorized AI-enabled solutions: GE HealthCare leads the industry in artificial intelligence innovation, topping the FDA’s list for the most AI-enabled device authorizations of any medical device company this year. These solutions are helping to transform clinical workflows, supporting fast and precise decision-making, and expanding access to high-quality care.

“For more than 125 years, GE HealthCare has pioneered technologies that transform patient care. And while we celebrate our heritage, we remain focused on what lies ahead: a future where care is more personalized, connected, and intelligent than ever before,” said Roland Rott, CEO and President of Imaging at GE HealthCare. “This year at RSNA, our new innovations continue that tradition, empowering clinicians and advancing the boundaries of what’s possible in healthcare.”

A legacy rooted in discovery

GE HealthCare has been shaping the future of healthcare for more than a century. From the invention of the first x-ray tube still in use in modern day imaging equipment to today’s innovation renaissance, its led advances that redefine diagnostic imaging and how clinicians treat and care for patients. The company’s presence at every RSNA since its inception in 1914 reflects an enduring commitment to advance radiology and support the imaging community.

This year, GE HealthCare commemorates a series of transformative achievements that have shaped the landscape of medical imaging and patient care:

• Sixty years of mammography: Since 1965, GE HealthCare has led mammography innovation—from developing the first dedicated X-ray machine to digital, 3D, and AI-powered technologies that enable early accurate diagnoses. This ongoing commitment to women’s health empowers clinicians and aims to improve outcomes worldwide.
• Twenty-five years of PET/CT: Since introducing the world’s first commercially available PET/CT system in 2001—an innovation that would redefine diagnostic imaging and help transform patient care—GE HealthCare has expanded access and helped elevate precision medicine across care pathways. By combining functional and anatomical imaging, PET/CT has become an essential tool for clinicians, helping them detect, stage, and monitor cancer with greater accuracy and confidence.
• A legacy of industry firsts: GE HealthCare’s history is marked by groundbreaking achievements, including the development of the first full body CT scanner, the commercialization of magnetic resonance imaging (MR), the introduction of the first color pocket-size handheld ultrasound, Vscan, in 2010, and Flyrcado in 2024, a first-of-its kind PET molecular imaging agent for diagnosing and assessing coronary artery disease, a significant game-changing innovation for nuclear cardiology. Each innovation is designed to set new standards for patient care and clinical excellence.

Strategic collaborations driving innovation

GE HealthCare’s commitment to advancing patient care goes beyond research and development—it’s strengthened by strategic collaborations and acquisitions that accelerate innovation. In the past year, the company has strengthened its portfolio to include:

• MIM Software, which enhances GE HealthCare’s ability to provide advanced imaging analytics, visualization, and workflow solutions
• Spectronic Medical, delivering innovations that aim to enhance radiation oncology planning
• icometrix, which further expands GE HealthCare’s leadership in AI-enabled precision imaging, facilitating neurological disorder diagnosis and monitoring of disease progression

For more information on GE HealthCare and these innovative solutions at RSNA, visit booth 7334, explore the press kit, or the RSNA 2025 events page.

Important Safety Information and Usage of Flyrcado™ (flurpiridaz F 18) injection

Indications and Usage

FLYRCADO is a radioactive diagnostic drug indicated for positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease (CAD) to evaluate for myocardial ischemia and infarction.

Contraindications

None

Warnings and Precautions

• Risk associated with exercise or pharmacologic stress: Patients evaluated with exercise or pharmacologic stress may experience serious adverse reactions such as myocardial infarction, arrhythmia, hypotension, bronchoconstriction, stroke, and seizure. Perform stress testing in the setting where cardiac resuscitation equipment and trained staff are readily available. When pharmacologic stress is selected as an alternative to exercise, perform the procedure in accordance with the pharmacologic stress agent’s prescribing information.
• Radiation risks: FLYRCADO contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. Ensure safe handling to minimize radiation exposure to patients and health care providers. Advise patients to hydrate before and after administration and to void.

Adverse Reactions

• Most common adverse reactions occurring during FLYRCADO PET MPI under rest and stress (pharmacologic or exercise) (incidence ≥ 2%) are dyspnea, headache, angina pectoris, chest pain, fatigue, ST segment changes, flushing, nausea, abdominal pain, dizziness, and arrhythmia.

Use in Specific Populations

• Pregnancy
  • There are no data on use of flurpiridaz F 18 in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. If considering FLYRCADO administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes based on the radiation dose from flurpiridaz F 18 and the gestational timing of exposure.
  • FLYRCADO contains ethanol (a maximum daily dose of 337 mg anhydrous ethanol). If considering FLYRCADO administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes associated with ethanol exposure during pregnancy.
• Lactation
  • Temporarily discontinue breastfeeding. A lactating woman should pump and discard breastmilk for at least 8 hours after FLYRCADO administration.
• Pediatric Use
  • Safety and effectiveness of FLYRCADO in pediatric patients have not been established.

To report SUSPECTED ADVERSE REACTIONS, contact GE HealthCare at 800-654-0118 (option 2 then option 1) or by email at GPV.drugsafety@gehealthcare.com or FDA at 800-FDA-1088 or www.fda.gov/medwatch

For full prescribing information, click here. For important safety information, please click here.

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

¹ Elizabeth H. Dibble et al. “Workforce Shortage and Strategies for Mitigation: Results from the 2022 ACR/Radiology Business Management Association Workforce Survey.” Journal of the American College of Radiology 22, no. 5 (2025): 573–576. https://doi.org/10.1016/j.jacr.2025.01.xxx.

² Photonova Spectra is 510(k)-pending with the U.S. FDA. Not CE Marked. Not available for sale in the United States, Europe, Canada, or any other region.

³ Enhanced Boundary for PCCT is 510(k)-pending with the U.S. FDA. Not CE Marked. Not available for sale in the United States, Europe, Canada, or any other region.

⁴ When compared to Revolution Apex Elite.

⁵ SIGNA Bolt is 510(k) pending at U.S. FDA. Not CE marked. Not available for sale.

⁶ SIGNA Sprint with Freelium is a sealed configuration of SIGNA Sprint Select. SIGNA Sprint Select is 510(k) pending at U.S. FDA. Not CE marked. Not available for sale.

⁷ SIGNA One is 510(k) pending with the U.S. FDA. Not CE marked. Not available for sale.

⁸ Genesis Radiology Workspace consists of Genesis View, Enterprise Archive, Workflow Manager and App Orchestrator.

⁹ Genesis Viewer is 510(k) Pending at the U.S. FDA; not available for sale.

Contacts

Media Contact:
Catherine Carter

Senior Communications Manager

GE HealthCare

+1 414 396-1439

Catherine.Carter@gehealthcare.com

Lomiko Metals Announces Management Change




Lomiko Metals Announces Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MONTREAL–(BUSINESS WIRE)–Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) is pleased to announce the appointment of Robert Boisjoli as the Company’s Chief Financial Officer (CFO), effective immediately. Mr. Boisjoli, based in Montreal, replaces the company’s outgoing CFO, Jacqueline Michael.

Mr. Boisjoli, who is a Fellow Chartered Professional Accountant, is a corporate finance/operational professional with over 30 years of operational and advisory experience. He is the managing director of Atwater Financial Group, a company specializing in financial reporting services for listed mining companies. He is an advisor to various public exploration companies. Mr. Boisjoli was an investment banker with various Canadian securities firms. He is also a Board Member of CPA Professional Liability Plan Inc. and various nonprofit community organizations.

About Lomiko Metals Inc.

The Company holds mineral interests in its La Loutre graphite development in southern Quebec. The La Loutre project site is within the Kitigan Zibi Anishinabeg (KZA) First Nation’s territory. The KZA First Nation is part of the Algonquin Nation, and the KZA traditional territory is situated within the Outaouais and Laurentides regions. Located 180 kilometers northwest of Montreal, the property consists of one large, continuous block with 76 mineral claims totaling 4,528 hectares (45.3 km2).

The Property is underlain by rocks from the Grenville Province of the Precambrian Canadian Shield. The Grenville was formed under conditions that were very favorable for the development of coarse-grained, flake-type graphite mineralization from organic-rich material during high- temperature metamorphism.

Lomiko Metals published an updated Mineral Resource Estimate (MRE) in a NI 43-101 Technical Report and Mineral Resource Estimate Update for the La Loutre Project, Quebec, Canada, prepared by InnovExplo on May 11th, 2023, which estimated 64.7 million tonnes of Indicated Mineral Resources averaging 4.59% Cg per tonne for 3.0 million tonnes of graphite, a tonnage increase of 184%. Indicated Mineral Resources increased by 41.5 million tonnes as a result of the 2022 drilling campaign, from 17.5 million tonnes in 2021 MRE with additional Mineral resources reported down-dip and within marble units resulted in the addition of 17.5 million tonnes of Inferred Mineral Resources averaging 3.51% Cg per tonne for 0.65 million tonnes of contained graphite; and the additional 13,107 metres of infill drilling in 79 holes completed in 2022 combined with the refinement of the deposit and structural models contributed to the addition of most of the Inferred Mineral Resources to the Indicated Mineral Resource category, relative to the 2021 Mineral Resource Estimate. The MRE assumes a US$1,098.07 per tonne graphite price and a cut-off grade of 1.50% Cg (graphitic carbon). The independent and qualified persons for the mineral resource estimate, as defined by NI 43 101, are Marina Iund, P.Geo. (InnovExplo Inc.), Martin Perron, P.Eng. (InnovExplo Inc.)., Simon Boudreau, P.Eng. (InnovExplo Inc.). and Pierre Roy, P.Eng. (Soutex Inc.). The effective date of the estimate is May 11, 2023.

The Company also holds interest in seven early-stage projects in southern Quebec, including Ruisseau, Tremblant, Meloche, Boyd, Dieppe, North Low and Carmin, covering 328 claims in total on 7 early-stage projects covering 18,622 hectares in the Laurentian region of Quebec and within KZA territory.

The stage graphite portfolio consists of 328 claims in total on seven early-stage projects covering 18,622 hectares in southern Quebec. The grades presented below for the Laurentides graphite portfolio were press-released on January 7^th, 2025. (https://lomiko.com/news/lomiko-metals– encounters-up-to-27-9-graphite-at-its-laurentides-early-stage-projects-including-the-discovery-of-four- new-zones-at-the-ruisseau-project-spanning-over-3-kilometres-long/)

• Ruisseau–grades up to 27.9 percent carbon graphite (“% Cg”) from four distinct high grade mineralized zones that are over 3km long;
• Meloche –grades up to 13.3% Cg from two distinct mineralized clusters;
• Tremblant –grades up to 11.6% Cg from numerous, widespread spot anomalies; and
• Dieppe –grades up to 6.82% Cg from numerous, widespread spot anomalies and a distinct mineralized cluster.
• Boyd–8 samples grades range from 5.61% Cg to 17.10 %Cg with all samples above 5.00% Cg. The technical content regarding the exploration results presented was reviewed by Mark Fekete, P.Geo. who acts as an independent consultant to the Company and is the Qualified Person.

The Yellow Fox Property is located approximately 10 km southwest of the Town of Glenwood NL, and south of the Trans-Canada Highway. The Property occurs within NTS map sheets 02D/14 and 15 with excellent access along several logging and skidder roads originating from Glenwood. The main Yellow Fox showing is located in the central part of License 027536M, 5km from the western end of Gander Lake.

This property is on the same trend as the past-producing antimony mine Beaver Brook, which is located 25km southwest of the property. Yellow Fox is an early-stage exploration property prospective in antimony, gold, and silver where historic works returned samples anomalous in gold (Au), antimony (Sb), lead (Pb), zinc (Zn), and silver (Ag). The trenching exposed the rocks, resulting in grab samples to 59.43g/t Au, 11.10% Sb, 7.00% Zn, 72.90g/t Ag, and 5.50% Pb in arsenopyrite-stibnite veins within altered monzogranite. (See Metals Creek assessment report at https://gis.geosurv.gov.nl.ca/geofilePDFS/Batch2016/002D_0779.pdf)

Lomiko QP relied on the information provided by Metals Creek. Metals Creek QP is Wayne Reid P.Geo. is registered in Newfoundland.

On behalf of the Board,

Gordana Slepcev

CEO & President and Director, Lomiko Metals Inc.

Signed: “Gordana Slepcev”

For more information on Lomiko Metals, review the website at www.lomiko.com. Contact us at 1-833-4-LOMIKO or e-mail: info@lomiko.com.

Contacts

1-833-4-LOMIKO

info@lomiko.com

Lomiko Metals Announces Management Change




Lomiko Metals Announces Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MONTREAL–(BUSINESS WIRE)–Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) is pleased to announce the appointment of Robert Boisjoli as the Company’s Chief Financial Officer (CFO), effective immediately. Mr. Boisjoli, based in Montreal, replaces the company’s outgoing CFO, Jacqueline Michael.

Mr. Boisjoli, who is a Fellow Chartered Professional Accountant, is a corporate finance/operational professional with over 30 years of operational and advisory experience. He is the managing director of Atwater Financial Group, a company specializing in financial reporting services for listed mining companies. He is an advisor to various public exploration companies. Mr. Boisjoli was an investment banker with various Canadian securities firms. He is also a Board Member of CPA Professional Liability Plan Inc. and various nonprofit community organizations.

About Lomiko Metals Inc.

The Company holds mineral interests in its La Loutre graphite development in southern Quebec. The La Loutre project site is within the Kitigan Zibi Anishinabeg (KZA) First Nation’s territory. The KZA First Nation is part of the Algonquin Nation, and the KZA traditional territory is situated within the Outaouais and Laurentides regions. Located 180 kilometers northwest of Montreal, the property consists of one large, continuous block with 76 mineral claims totaling 4,528 hectares (45.3 km2).

The Property is underlain by rocks from the Grenville Province of the Precambrian Canadian Shield. The Grenville was formed under conditions that were very favorable for the development of coarse-grained, flake-type graphite mineralization from organic-rich material during high- temperature metamorphism.

Lomiko Metals published an updated Mineral Resource Estimate (MRE) in a NI 43-101 Technical Report and Mineral Resource Estimate Update for the La Loutre Project, Quebec, Canada, prepared by InnovExplo on May 11th, 2023, which estimated 64.7 million tonnes of Indicated Mineral Resources averaging 4.59% Cg per tonne for 3.0 million tonnes of graphite, a tonnage increase of 184%. Indicated Mineral Resources increased by 41.5 million tonnes as a result of the 2022 drilling campaign, from 17.5 million tonnes in 2021 MRE with additional Mineral resources reported down-dip and within marble units resulted in the addition of 17.5 million tonnes of Inferred Mineral Resources averaging 3.51% Cg per tonne for 0.65 million tonnes of contained graphite; and the additional 13,107 metres of infill drilling in 79 holes completed in 2022 combined with the refinement of the deposit and structural models contributed to the addition of most of the Inferred Mineral Resources to the Indicated Mineral Resource category, relative to the 2021 Mineral Resource Estimate. The MRE assumes a US$1,098.07 per tonne graphite price and a cut-off grade of 1.50% Cg (graphitic carbon). The independent and qualified persons for the mineral resource estimate, as defined by NI 43 101, are Marina Iund, P.Geo. (InnovExplo Inc.), Martin Perron, P.Eng. (InnovExplo Inc.)., Simon Boudreau, P.Eng. (InnovExplo Inc.). and Pierre Roy, P.Eng. (Soutex Inc.). The effective date of the estimate is May 11, 2023.

The Company also holds interest in seven early-stage projects in southern Quebec, including Ruisseau, Tremblant, Meloche, Boyd, Dieppe, North Low and Carmin, covering 328 claims in total on 7 early-stage projects covering 18,622 hectares in the Laurentian region of Quebec and within KZA territory.

The stage graphite portfolio consists of 328 claims in total on seven early-stage projects covering 18,622 hectares in southern Quebec. The grades presented below for the Laurentides graphite portfolio were press-released on January 7^th, 2025. (https://lomiko.com/news/lomiko-metals– encounters-up-to-27-9-graphite-at-its-laurentides-early-stage-projects-including-the-discovery-of-four- new-zones-at-the-ruisseau-project-spanning-over-3-kilometres-long/)

• Ruisseau–grades up to 27.9 percent carbon graphite (“% Cg”) from four distinct high grade mineralized zones that are over 3km long;
• Meloche –grades up to 13.3% Cg from two distinct mineralized clusters;
• Tremblant –grades up to 11.6% Cg from numerous, widespread spot anomalies; and
• Dieppe –grades up to 6.82% Cg from numerous, widespread spot anomalies and a distinct mineralized cluster.
• Boyd–8 samples grades range from 5.61% Cg to 17.10 %Cg with all samples above 5.00% Cg. The technical content regarding the exploration results presented was reviewed by Mark Fekete, P.Geo. who acts as an independent consultant to the Company and is the Qualified Person.

The Yellow Fox Property is located approximately 10 km southwest of the Town of Glenwood NL, and south of the Trans-Canada Highway. The Property occurs within NTS map sheets 02D/14 and 15 with excellent access along several logging and skidder roads originating from Glenwood. The main Yellow Fox showing is located in the central part of License 027536M, 5km from the western end of Gander Lake.

This property is on the same trend as the past-producing antimony mine Beaver Brook, which is located 25km southwest of the property. Yellow Fox is an early-stage exploration property prospective in antimony, gold, and silver where historic works returned samples anomalous in gold (Au), antimony (Sb), lead (Pb), zinc (Zn), and silver (Ag). The trenching exposed the rocks, resulting in grab samples to 59.43g/t Au, 11.10% Sb, 7.00% Zn, 72.90g/t Ag, and 5.50% Pb in arsenopyrite-stibnite veins within altered monzogranite. (See Metals Creek assessment report at https://gis.geosurv.gov.nl.ca/geofilePDFS/Batch2016/002D_0779.pdf)

Lomiko QP relied on the information provided by Metals Creek. Metals Creek QP is Wayne Reid P.Geo. is registered in Newfoundland.

On behalf of the Board,

Gordana Slepcev

CEO & President and Director, Lomiko Metals Inc.

Signed: “Gordana Slepcev”

For more information on Lomiko Metals, review the website at www.lomiko.com. Contact us at 1-833-4-LOMIKO or e-mail: info@lomiko.com.

Contacts

1-833-4-LOMIKO

info@lomiko.com

UK Accounts Payable Training Course | Practical Skills and Knowledge to Streamline and Manage Accounts Payable Processes Effectively Within Your Organisation – ResearchAndMarkets.com




UK Accounts Payable Training Course | Practical Skills and Knowledge to Streamline and Manage Accounts Payable Processes Effectively Within Your Organisation – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Accounts Payable Training Course (June 17, 2025)” training has been added to ResearchAndMarkets.com’s offering.

Our course provides an in-depth understanding of Accounts Payable management, covering essential areas such as invoice processing, vendor management, payment procedures, and financial reporting. By enrolling in this course, you’ll acquire practical skills and knowledge to streamline and manage Accounts Payable processes effectively within your organisation.

Elevate your career with our Accounts Payable course and become an invaluable asset to your company’s financial department. Sign up today and take the first step towards a more organised and efficient Accounts Payable department.

Boost your Accounts Payable expertise with our comprehensive training course, specifically designed for the UK market. Accounts Payable is a crucial cog in the financial machinery of any organisation. It not only plays a pivotal role in financial reporting but also in aligning the company’s objectives.

Who Should Attend:

This course is designed for individuals who are interested in expanding their knowledge and skills in the field of accounts payable. Specifically, this course is suitable for individuals who are currently working or intend to work in an Accounts Payable department.

This may include Accounts Payable clerks, supervisors, managers, and other professionals who are responsible for managing the Accounts Payable process in an organisation.

The course is also suitable for finance professionals and business owners who want to gain a better understanding of accounts payable and their role in financial reporting. Overall, this course is an excellent opportunity for individuals who want to enhance their knowledge of accounts payable and learn how to manage the process effectively in an organisational setting.

Everyone who completes the course gets:

• A Course Completion Certificate (on the success of your assessments, where applicable).

What are the Course Requirements?

There are no prerequisites or entry requirements, as long as you want to get more experience in the field of Accounts Payable, this is the right place for you.

What will be the Career Path?

• Accounts Assistant
• Accounts Payable Supervisor
• Accounts Payable Team Leader
• Purchase Ledger Controller

What is provided with the Course?

• Course Material
• Recording of Training
• Aftercare Course Support

Key Topics Covered:

• Understanding the importance of your role
• Capital and revenue expenditure
• Setting up new supplier accounts
• Introduction to VAT in relation to the Accounts Payable role
• Key considerations when processing invoices and credit notes
• Spotting errors and mistakes promptly and avoiding duplicate payments
• Maximising supplier discounts
• Performing supplier statement reconciliations
• Reviewing the Aged Creditors Listing
• Internal checks and controls; error and fraud prevention and detection
• Understanding the role of auditors and what you can do to prepare for their visit
• Paperless AP technology

For more information about this training visit https://www.researchandmarkets.com/r/a44j2t

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Vantage Data Centers Completes $1.6B Investment in APAC Platform from GIC and ADIA; Closes Acquisition of Yondr’s 300MW+ Hyperscale Campus in Johor, Malaysia




Vantage Data Centers Completes $1.6B Investment in APAC Platform from GIC and ADIA; Closes Acquisition of Yondr’s 300MW+ Hyperscale Campus in Johor, Malaysia

Milestones position Vantage as a leading digital infrastructure provider in APAC with 1GW of operational and planned capacity across the region

DENVER & SINGAPORE–(BUSINESS WIRE)–Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced that it has completed a $1.6 billion equity investment into its Asia-Pacific platform led by an affiliate of GIC, a global institutional investor, and a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”). Part of this capital was allocated to close the acquisition of Yondr Group’s 300MW+ hyperscale data center campus located in Sedenak Tech Park, Johor, Malaysia.

The transaction, initially announced in September, expands Vantage’s regional platform to 1GW of operational and planned IT capacity across Australia, Malaysia, Japan, Taiwan and Hong Kong. The addition of the Johor campus marks Vantage’s third campus in Malaysia and strengthens its ability to serve customers with direct access to other key Asia-Pacific markets, including Singapore, Indonesia and Thailand.

“DigitalBridge’s vision and long-standing investment, now bolstered by new commitments from anchor investors GIC and ADIA, will drive our continued growth and expansion in the region,” said Jeremy Deutsch, president of Vantage Data Centers, APAC. “Finalizing the acquisition of this campus in Johor marks an important step in our growth strategy for APAC. We are bringing one of Southeast Asia’s largest and most advanced hyperscale campuses into our platform, enhancing our ability to deliver sustainable and scalable infrastructure for AI and cloud customers across the region at rapid speed and scale.

“We’re thrilled to welcome more than 30 Yondr APAC team members into the Vantage APAC family. We look forward to their contributions as we expand and support our customers in the locations that matter most.”

The Johor campus, JHB1, sits on nearly 73 acres and will deliver more than 300MW of IT capacity across three data centers once fully developed. Located within the Johor-Singapore Special Economic Zone, JHB1 offers strategic connectivity with dark fiber routes and access to regional hubs. The campus was originally financed through a green loan and features sustainability-focused technologies, including direct-to-chip liquid cooling. The data center campus is also on track to meet EDGE certification standards.

To learn more about Vantage’s expanding APAC platform, please visit: https://vantage-dc.com/data-center-locations/apac/.

About Vantage Data Centers

Vantage Data Centers is a global leader in digital infrastructure serving the world’s most influential AI and cloud providers. With operations spanning North America, EMEA and Asia Pacific, Vantage delivers capacity at unrivaled speed and scale, driven by a relentless commitment to operational excellence and customer success. Vantage is empowering transformative companies to shape the future.

For more information, visit http://www.vantage-dc.com.

Contacts

Press
Mark Freeman

Vantage Data Centers

mfreeman@vantage-dc.com
+1-202-680-4243

Robin Bectel

REQ for Vantage Data Centers

vdc@req.co
+1-202-936-6335

Brenda Fong

Vantage Data Centers

brenda.fong@vantage-dc.com
+852-9466-4788

Sovina Taneja

Creative Consulting Group for Vantage Data Centers, APAC

sovina.taneja@creativegp.com
+852-5643-2495

Vantage Data Centers Completes $1.6B Investment in APAC Platform from GIC and ADIA; Closes Acquisition of Yondr’s 300MW+ Hyperscale Campus in Johor, Malaysia




Vantage Data Centers Completes $1.6B Investment in APAC Platform from GIC and ADIA; Closes Acquisition of Yondr’s 300MW+ Hyperscale Campus in Johor, Malaysia

Milestones position Vantage as a leading digital infrastructure provider in APAC with 1GW of operational and planned capacity across the region

DENVER & SINGAPORE–(BUSINESS WIRE)–Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced that it has completed a $1.6 billion equity investment into its Asia-Pacific platform led by an affiliate of GIC, a global institutional investor, and a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”). Part of this capital was allocated to close the acquisition of Yondr Group’s 300MW+ hyperscale data center campus located in Sedenak Tech Park, Johor, Malaysia.

The transaction, initially announced in September, expands Vantage’s regional platform to 1GW of operational and planned IT capacity across Australia, Malaysia, Japan, Taiwan and Hong Kong. The addition of the Johor campus marks Vantage’s third campus in Malaysia and strengthens its ability to serve customers with direct access to other key Asia-Pacific markets, including Singapore, Indonesia and Thailand.

“DigitalBridge’s vision and long-standing investment, now bolstered by new commitments from anchor investors GIC and ADIA, will drive our continued growth and expansion in the region,” said Jeremy Deutsch, president of Vantage Data Centers, APAC. “Finalizing the acquisition of this campus in Johor marks an important step in our growth strategy for APAC. We are bringing one of Southeast Asia’s largest and most advanced hyperscale campuses into our platform, enhancing our ability to deliver sustainable and scalable infrastructure for AI and cloud customers across the region at rapid speed and scale.

“We’re thrilled to welcome more than 30 Yondr APAC team members into the Vantage APAC family. We look forward to their contributions as we expand and support our customers in the locations that matter most.”

The Johor campus, JHB1, sits on nearly 73 acres and will deliver more than 300MW of IT capacity across three data centers once fully developed. Located within the Johor-Singapore Special Economic Zone, JHB1 offers strategic connectivity with dark fiber routes and access to regional hubs. The campus was originally financed through a green loan and features sustainability-focused technologies, including direct-to-chip liquid cooling. The data center campus is also on track to meet EDGE certification standards.

To learn more about Vantage’s expanding APAC platform, please visit: https://vantage-dc.com/data-center-locations/apac/.

About Vantage Data Centers

Vantage Data Centers is a global leader in digital infrastructure serving the world’s most influential AI and cloud providers. With operations spanning North America, EMEA and Asia Pacific, Vantage delivers capacity at unrivaled speed and scale, driven by a relentless commitment to operational excellence and customer success. Vantage is empowering transformative companies to shape the future.

For more information, visit http://www.vantage-dc.com.

Contacts

Press
Mark Freeman

Vantage Data Centers

mfreeman@vantage-dc.com
+1-202-680-4243

Robin Bectel

REQ for Vantage Data Centers

vdc@req.co
+1-202-936-6335

Brenda Fong

Vantage Data Centers

brenda.fong@vantage-dc.com
+852-9466-4788

Sovina Taneja

Creative Consulting Group for Vantage Data Centers, APAC

sovina.taneja@creativegp.com
+852-5643-2495

ISG Announces 2025 ISG Paragon Awards™ Asia Winners




ISG Announces 2025 ISG Paragon Awards™ Asia Winners

Program spotlights innovative approaches that leverage AI, digital technology and new operating models to drive business success

SINGAPORE–(BUSINESS WIRE)–#AI–Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has announced the winners of the inaugural 2025 ISG Paragon Awards™ Asia, which recognize innovative approaches that help enterprises leverage technology to make a significant and lasting impact on their businesses.

The following winners were selected by an independent, external judge and announced at a gala awards dinner at the Fullerton Bay Hotel, Singapore, on November 12, 2025:

Best-in-Class Excellence: Outstanding delivery by a technology or service provider

• Avanade with Country Foods, a subsidiary of SATS Ltd.

Innovation: Imagination and entrepreneurial spirit in helping organizations future-proof their businesses and better serve clients

• Tech Mahindra with Mahindra Auto and Farm

Transformation: The successful transformation of an organization or key business function

• Tata Consultancy Services with Plaza Premium Group

AI Pacesetter: Substantial business impact through the adoption of AI

• Avanade with Alexandra Group

iCompaz, an Infosys and Temasek company, and Temasek Holdings (Pte) Ltd., were selected by the independent judge to receive the Paragon Asia Honorary Distinction for Partnership Excellence, recognizing a high-performing partnership that exemplifies best practices in driving exceptional business outcomes and economic growth.

“Congratulations to the winners of the first-ever ISG Paragon Awards program for Asia,” said Michael Gale, partner and regional leader, ISG Asia Pacific. “Providers across Asia are delivering critical innovation and support for enterprises looking to leverage and scale AI and other technologies for business value. We are delighted to expand the Paragon Awards program to cover this dynamic and growing market.”

The ISG Paragon Awards were established in 2010 in the Australia/New Zealand region, and have since expanded to cover North America, Europe, the Middle East and Africa and South America. Full details are available here.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.

Contacts

Press Contacts:

Laura Hupprich, ISG

+1 203 517 3100

Laura.Hupprich@isg-one.com

Julianna Sheridan, Matter Communications for ISG

+1 978 518 4520

isg@matternow.com

U.S. Original Equipment Automotive Industry Must Transform and Collaborate for Future Resilience and Relevance Finds Joint Research by Arthur D. Little and MEMA OE Suppliers




U.S. Original Equipment Automotive Industry Must Transform and Collaborate for Future Resilience and Relevance Finds Joint Research by Arthur D. Little and MEMA OE Suppliers

SOUTHFIELD, Mich. & NEW YORK–(BUSINESS WIRE)–At a time of unprecedented volatility, the U.S. original equipment (OE) automotive industry is at an inflection point. Building resilience and driving reshoring requires concerted actions from policymakers, original equipment manufacturers and suppliers. This is the key message from Turbocharging US Automotive Manufacturing Competitiveness, an in-depth Arthur D. Little (ADL) landmark study, carried out in conjunction with industry body MEMA Original Equipment Suppliers.

The study draws on research from over 100 global OE automotive suppliers with major U.S. presence and more than 30 interviews with C-suite executives of leading global OE automotive suppliers. Based on ADL analysis, the research provides clear recommendations for transforming the industry to strengthen supply chain resilience and underpin national competitiveness and global relevance.

High import dependence exposes the U.S. OE automotive supply chain to cost volatility and geopolitical risk. Current reshoring efforts, driven by policy incentives and industry realignment, not only bring production home, but also secure long-term supply resilience and technology leadership.

The report analyzes the viability of this approach and critical gaps that remain across all major groups of auto parts and systems: body and chassis, EV batteries and motors, ICE engines and transmissions, interior and plastics, tires and rubber and electrics and electronics. It also examines how these groups are shaped by four key factors: labor, automation, supply chain, and regulation/policy.

Key constraints affecting all component categories, as highlighted by the research, include persistent skilled labor shortages, limited automation capabilities and a weak domestic supply base for industrial machinery. These challenges all stem from an overarching lack of historic holistic industrial policies comparable to competing countries.

Solving these bottlenecks must be balanced with the ongoing shift in vehicle architectures which will require building capabilities in high-performance semiconductors, advanced electronics, EV systems and software-defined integration. Each of these are also critical to adjacent industries such as aerospace and defense, construction and agricultural equipment, and marine and powersports.

Joern Buss, Partner, Automotive and Manufacturing Group, at Arthur D. Little, comments: “The US automotive supply chain faces unprecedented pressures, from technology shifts to geopolitical tensions. Ensuring its continued competitiveness and relevance requires close collaboration to reshape the industry. Our report highlights the strategic levers that will propel this transformation and the actions needed to foster change.”

Collin Shaw, president of MEMA Original Equipment Suppliers commented: “Vehicle suppliers are the largest manufacturing sector in the U.S. and a cornerstone of our national economy. Developed with industry insight and ADL’s expertise, this landmark study offers a roadmap to strengthen U.S. supplier competitiveness, accelerate innovation, and ensure our industry continues to lead on the global stage.”

The full report can be downloaded here.

About Arthur D. Little

Arthur D. Little has been at the forefront of innovation since 1886. We are an acknowledged thought leader in linking strategy, innovation and transformation in technology-intensive and converging industries. We navigate our clients through changing business ecosystems to uncover new growth opportunities. We enable our clients to build innovation capabilities and transform their organizations.

Our consultants have strong practical industry experience combined with excellent knowledge of key trends and dynamics. ADL is present in the most important business centers around the world. We are proud to serve most of the Fortune 1000 companies, in addition to other leading firms and public sector organizations.

For further information, please visit www.adlittle.com.

About MEMA Original Equipment Suppliers

MEMA Original Equipment Suppliers exclusively serves vehicle original equipment (OE) suppliers, a part of the largest manufacturing sector in the United States and leading the way in new vehicle innovations. Members conceive, design, and manufacture the OE systems and technologies that make up two-thirds of the value of every vehicle, fueling international commerce and meeting society’s transportation needs. MEMA members are committed to safety and sustainability.

MEMA, The Vehicle Suppliers Association, is the leading trade association in North America for vehicle suppliers, parts manufacturers, and remanufacturers. It has been the voice of the vehicle supplier industry since 1904. Its more than 1,000 members are Strong by Association.

MEMA has offices in Southfield, Mich.; Research Triangle Park, N.C.; and Washington, D.C. Learn more at mema.org/original-equipment-suppliers.

Contacts

Media Contact:

For Arthur D. Little:
Sue Glanville

Catalyst Comms

+44 7715 817589

Glanville.sue@adlittle.com

For MEMA
Megan Gardner

MEMA

919-636-2941

mgardner@mema.org